Skip to main content
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.650
+0.185 (4.14%)
At close: Mar 9, 2026, 4:00 PM EDT
4.615
-0.035 (-0.75%)
After-hours: Mar 9, 2026, 4:10 PM EDT

TriSalus Life Sciences Revenue

In the year 2025, TriSalus Life Sciences had annual revenue of $45.15M with 53.41% growth. TriSalus Life Sciences had revenue of $13.21M in the quarter ending December 31, 2025, with 59.85% growth.

Revenue (ttm)
$45.15M
Revenue Growth
+53.41%
P/S Ratio
6.27
Revenue / Employee
$442,657
Employees
102
Market Cap
282.93M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202545.15M15.72M53.41%
Dec 31, 202429.43M10.92M58.99%
Dec 31, 202318.51M6.11M49.31%
Dec 31, 202212.40M4.00M47.58%
Dec 31, 20218.40M2.97M54.60%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Viemed Healthcare 270.28M
Cerus 206.13M
Quanterix 138.90M
RxSight 134.48M
Standard BioTools 85.33M
Delcath Systems 85.23M
Sight Sciences 77.36M
908 Devices 56.20M
Revenue Rankings

TLSI News

More News